Back to Companypage
Business Logo
 
  • Konzern
    • About us
    • Management
    • Press
    • Events
    • Employees
    • Careers
    • Sponsoring
  • Business Units
    • Analytical Instrumentation
    • Life Science
    • Optics
  • Produkte
    • Products from A to Z
  • Investor | Media Relations
    • Key Figures
    • Share
    • Financial Reports
    • Annual Document
    • Corporate Governance
    • Ad Hoc Announcements
    • Director’s Dealings
    • Annual General Meeting
    • Financial Calendar
    • Press Releases
Company Group
  • About us
    • Business Model
    • History
    • Corporate Structure
    • Locations
    • References
  • Management
  • Press
  • Events
  • Employees
  • Careers
  • Sponsoring
  • Contact

Analytik Jena Company

  • AJ Blomesystem GmbH
  • AJ Cybertron GmbH
  • AJ Innuscreen GmbH
  • AJ Roboscreen GmbH
  • AJZ Engineering GmbH
  • Biometra GmbH
  • CyBio AG
  • Analytik Jena Worldwide |
  • Languages
    • English
    • Deutsch
 

zurück zur Übersicht

Analytik Jena AG Resolves Capital Increase

Jena (Germany), January 26, 2012 - On January 25, 2012, the Executive Board of Analytik Jena AG (Prime Standard: AJA, ISIN: DE0005213508) utilized the authorization granted by the Annual General Meeting on March 19, 2009 and resolved a cash capital increase from authorized capital. The Super-visory Board of Analytik Jena today approved the capital increase.

The share capital of the Company from the current figure of EUR 5,235,465.00 will be increased by partially utilizing the Authorized Capital by issuing 470,000 new no-par value bearer shares at a sub-scription price of EUR 10.480 per share with shareholders' subscription rights disapplied. The sub-scription price corresponds to the volume-weighted average price on the last five trading days (Xetra) less a discount of 3 %. The new shares will be fully subscribed by the Thüringer Industriebeteiligungs-GmbH & Co. KG (TIB), an investment fund managed by the bm-t beteilungsmanagement thüringen gmbh (bm-t), Erfurt. bm-t already holds an interest in Analytik Jena AG of 10.41 % and thus increases its stake to 17.79 %.

Analytik Jena AG intends to use the proceeds from the capital increase to finance the strategic devel-opment of the Company.

Analytik Jena has commissioned IKB Deutsche Industriebank AG to manage the transaction.

"Following a successful 2010/2011 financial year, we are looking to continue Analytik Jena's growth path. The proceeds from the capital increase will be used for the further expansion of our business, particularly through additions to our portfolio that offer significant synergy effects. However, we cannot make any concrete statements at present," commented Klaus Berka, CEO of Analytik Jena AG. "We are pleased that, with its investment, bm-t is backing Analytik Jena's growth policy and strongly positioning itself as a long-term strategic investor."


Contact:
Dana Schmidt
Analytik Jena AG
Konrad-Zuse-Strasse 1
07745 Jena | Germany
Phone: +49 (0) 36 41 77 92 81
E-mail: ir@analytik-jena.com

 

 
AJ Blomesystem GmbH | AJ Cybertron GmbH | AJ Innuscreen GmbH
AJ Roboscreen GmbH | AJZ Engineering GmbH | Biometra GmbH | CyBio AG
Analytik Jena AG | Contact | Imprint | Conditions of Use | Privacy Policy | Sitemap